Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
14.17
-0.59 (-4.00%)
At close: May 15, 2026, 4:00 PM EDT
13.94
-0.23 (-1.62%)
After-hours: May 15, 2026, 6:27 PM EDT

Biodesix Revenue

Biodesix had revenue of $25.56M in the quarter ending March 31, 2026, with 42.30% growth. This brings the company's revenue in the last twelve months to $96.10M, up 29.05% year-over-year. In the year 2025, Biodesix had annual revenue of $88.50M with 24.08% growth.

Revenue (ttm)
$96.10M
Revenue Growth
+29.05%
P/S Ratio
1.49
Revenue / Employee
$287,713
Employees
334
Market Cap
143.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202588.50M17.18M24.08%
Dec 31, 202471.32M22.24M45.30%
Dec 31, 202349.09M10.88M28.46%
Dec 31, 202238.21M-16.29M-29.89%
Dec 31, 202154.51M8.95M19.64%
Dec 31, 202045.56M21.01M85.55%
Dec 31, 201924.55M4.12M20.16%
Dec 31, 201820.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
Castle Biosciences339.92M
Fulgent Genetics320.35M
MDxHealth110.97M
FONAR105.34M
Prenetics Global92.39M
Burning Rock Biotech77.14M
Exagen68.38M
Revenue Rankings